Effect of chain length and ring size of alkyl and cycloalkyl side-chain substituents upon the biological activity of brassinosteroids. Preparation ofnovel analogues with activity exceeding that of brassinolide
Tg. Back et al., Effect of chain length and ring size of alkyl and cycloalkyl side-chain substituents upon the biological activity of brassinosteroids. Preparation ofnovel analogues with activity exceeding that of brassinolide, J ORG CHEM, 65(10), 2000, pp. 3047-3052
A series of brassinosteroids with different alkyl or cycloalkyl substituent
s in place of the isopropyl group at C-24 of brassinolide (1) were prepared
by the CuCN-catalyzed addition of Grignard reagents to (threo-2R,3S,5 alph
a, 22R,23R,24S)-23,24-epoxy-6,6-(ethylenedioxy)-2,3-(isopropylidenedioxy)-2
6,27-dinorcholestan-22-ol (9), followed by deketalization and Baeyer-Villig
er oxidation. Compound 9 was employed as part of a 70:30 threo/erythro mixt
ure of epoxides 9 and 10, from which the erythro-epoxide 10 was recovered i
ntact after the Grignard additions. Thus, the corresponding n-dodecyl, n-he
xyl, n-propyl, tert-butyl, cyclohexyl, cyclopentyl, cyclobutyl, and cyclopr
opyl analogues of brassinolide were obtained. A rearrangement byproduct was
observed during the preparation of the cyclopropyl-substituted brassinoste
roid when ether was used as the solvent in the Grignard reaction, but could
be avoided by the use of THF. A method for recycling the undesired erythro
-epoxide 10 was developed on the basis of deoxygenation with tellurium and
lithium triethylboro- hydride. The rice leaf lamina inclination assay was t
hen used to measure the bioactivity of the products. In general, increasing
activity was observed as the length or ring size of the C-24 hydrocarbon s
ubstituent decreased. The novel cyclobutyl- and cyclopropyl-substituted ana
logues of brassinolide (1) were ca. 5-7 times as active as 1 and thus appea
r to be the most potent brassinosteroids reported to date. Further enhancem
ent of the bioactivity of all of the above brassinosteroids, except that of
the inactive n-dodecyl derivative, was observed when the brassinosteroid w
as applied together with an auxin, indole-3-acetic acid (IAA). The synergy
between the brassinosteroids and IAA thus increased the bioactivity of the
brassinosteroids, including the cyclopropyl and cyclobutyl derivatives, by
ca. 1-2 orders of magnitude.